---
figid: PMC4546755__JNA2015-143636.003
figtitle: Overview of carcinogenesis and NRF2 responses
organisms:
- NA
pmcid: PMC4546755
filename: JNA2015-143636.003.jpg
figlink: /pmc/articles/PMC4546755/figure/fig3/
number: F3
caption: Overview of carcinogenesis and NRF2 responses. Tumour progression is recognized
  to induce dysregulated miRNA expression, resulting in exacerbated NRF2 activity.
  Such downstream effects include reduced apoptotic mechanism induction and exacerbation
  of chemoresistance properties by the tumour, therefore thwarting any conventional
  cancer therapeutic success.
papertitle: miRNA Influences in NRF2 Pathway Interactions within Cancer Models.
reftext: Duncan Ayers, et al. J Nucleic Acids. 2015;2015:143636.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9274268
figid_alias: PMC4546755__F3
figtype: Figure
organisms_ner:
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC4546755__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4546755__JNA2015-143636.003.html
  '@type': Dataset
  description: Overview of carcinogenesis and NRF2 responses. Tumour progression is
    recognized to induce dysregulated miRNA expression, resulting in exacerbated NRF2
    activity. Such downstream effects include reduced apoptotic mechanism induction
    and exacerbation of chemoresistance properties by the tumour, therefore thwarting
    any conventional cancer therapeutic success.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mir365-1
  - mir193b
  - mir9-3
  - mir93
  - mir27a
  - mir144
  - nfe2l2a
  - mir141
  - cul3a
  - keap1a
  - mir125b-1
  - dre-mir-29b-1
  - mir200a
  - MIR3651
  - MIR365A
  - MIR193B
  - MIR28
  - MIR93
  - MIR27A
  - MIR144
  - GABPA
  - NFE2L2
  - MIR141
  - MIR340
  - CUL3
  - KEAP1
  - MIR125B1
  - MIR29B1
  - MIR200A
---
